Investigation of treatment continuity, usefulness, and nocebo effect in switching from the original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Japanese clinical practice.
- DOI
- 10.1093/mr/road027
- Published
- 2024 Feb 26
- Container
- Modern rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/mr/road027,
title = {Investigation of treatment continuity, usefulness, and nocebo effect in switching from the original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Japanese clinical practice.},
author = {Matsubara T and Katayama K and Sagawa A and Yoshida M and Mitsuka T and Hashimoto K and Izumihara T and Kondo M and Izumiyama T and Miyake N and Yoshii I and Oribe M and Momohara S and Funahashi K},
year = {2024},
journal = {Modern rheumatology},
doi = {10.1093/mr/road027},
url = {https://doi.org/10.1093/mr/road027}
}RIS
TY - JOUR TI - Investigation of treatment continuity, usefulness, and nocebo effect in switching from the original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Japanese clinical practice. AU - Matsubara T AU - Katayama K AU - Sagawa A AU - Yoshida M AU - Mitsuka T AU - Hashimoto K AU - Izumihara T AU - Kondo M AU - Izumiyama T AU - Miyake N AU - Yoshii I AU - Oribe M AU - Momohara S AU - Funahashi K PY - 2024 JO - Modern rheumatology DO - 10.1093/mr/road027 UR - https://doi.org/10.1093/mr/road027 ER -
APA
T, M., K, K., A, S., M, Y., T, M., K, H., T, I., M, K., T, I., N, M., I, Y., M, O., S, M., & K, F. (2024). Investigation of treatment continuity, usefulness, and nocebo effect in switching from the original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Japanese clinical practice.. Modern rheumatology. https://doi.org/10.1093/mr/road027
Source records
- pubmed · retrieved 2026-09-26T07:17:08.570Z